Pulmicort-100



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Asthma 52.6%
Chronic Obstructive Pulmonary Disease 14.5%
Dyspnoea 5.1%
Emphysema 4.7%
Cough 3.4%
Hypertension 3.0%
Blood Cholesterol Abnormal 2.1%
Bronchitis 2.1%
Seasonal Allergy 1.7%
Bronchitis Chronic 1.3%
Lung Disorder 1.3%
Vitamin Supplementation 1.3%
Anticoagulant Therapy 0.9%
Benign Prostatic Hyperplasia 0.9%
Chronic Sinusitis 0.9%
Diarrhoea 0.9%
Hiv Infection 0.9%
Hypokalaemia 0.9%
Nasopharyngitis 0.9%
Pain 0.9%
Dyspnoea 13.2%
Asthma 8.8%
Wheezing 7.7%
Drug Ineffective 6.6%
Malaise 5.5%
Pneumonia 5.5%
Rhinorrhoea 5.5%
Throat Irritation 5.5%
Tremor 5.5%
Nervousness 4.4%
Hypersensitivity 3.3%
Ill-defined Disorder 3.3%
Increased Appetite 3.3%
Medication Error 3.3%
Nasal Congestion 3.3%
Pain In Extremity 3.3%
Sinusitis 3.3%
Weight Decreased 3.3%
Weight Increased 3.3%
Abdominal Distension 2.2%
Secondary
Asthma 28.0%
Chronic Obstructive Pulmonary Disease 20.8%
Drug Use For Unknown Indication 11.4%
Cough 5.5%
Blood Cholesterol Abnormal 4.2%
Dyspnoea 3.8%
Bronchitis 3.4%
Gout 3.4%
Emphysema 3.0%
Hypertension 3.0%
Prophylaxis 2.5%
Cardiac Failure 1.7%
Cardiac Failure Chronic 1.7%
Myasthenia Gravis 1.7%
Cardiac Disorder 1.3%
Osteoporosis 1.3%
Cerebral Infarction 0.8%
Cholelithiasis 0.8%
Hypokalaemia 0.8%
Hypothyroidism 0.8%
Vomiting 12.3%
Wrong Drug Administered 10.5%
Pneumonia 8.8%
Wheezing 8.8%
Throat Irritation 5.3%
Tremor 5.3%
Asthma 3.5%
Chills 3.5%
Drug Dose Omission 3.5%
Dyspnoea 3.5%
Emphysema 3.5%
Erythema 3.5%
Haemoptysis 3.5%
Head Injury 3.5%
Interstitial Lung Disease 3.5%
Nightmare 3.5%
Sepsis 3.5%
Tinea Infection 3.5%
Tinnitus 3.5%
Tubulointerstitial Nephritis 3.5%
Concomitant
Drug Use For Unknown Indication 42.1%
Asthma 21.6%
Chronic Obstructive Pulmonary Disease 7.9%
Hypersensitivity 4.7%
Hypertension 4.5%
Product Used For Unknown Indication 2.3%
Gastrooesophageal Reflux Disease 2.2%
Pain 1.9%
Rheumatoid Arthritis 1.6%
Depression 1.5%
Emphysema 1.4%
Diabetes Mellitus 1.2%
Osteoporosis 1.0%
Blood Cholesterol Increased 0.9%
Cardiac Disorder 0.9%
Rhinitis Allergic 0.9%
Anxiety 0.9%
Pyrexia 0.8%
Hiv Infection 0.8%
Type 2 Diabetes Mellitus 0.8%
Vomiting 12.4%
Weight Decreased 7.0%
Pneumonia 6.6%
Drug Exposure During Pregnancy 6.2%
Death 5.8%
Pyrexia 5.8%
Dyspnoea 5.4%
Status Asthmaticus 5.4%
Lymphadenopathy 5.0%
Thrombocytopenia 4.5%
Vasculitis 4.5%
Drug Ineffective 4.1%
Urticaria 4.1%
Weight Increased 4.1%
Tubulointerstitial Nephritis 3.7%
Depression 3.3%
Respiratory Distress 3.3%
Oedema Peripheral 2.9%
Throat Irritation 2.9%
Upper Respiratory Tract Infection 2.9%